I was surprised the actual results were materially worse than the consensus forecast published 10 November 2023. Some of this was due to additional provisioning which might turn out to be conservative. Looking on the bright side, the share buyback will be done at lower prices (assuming the share price stays down) so that should result in fewer shares on issue over time. Whenever the buy back finishes (the consensus is 2025), then that should mean much higher dividends for shareholders by 2026, all other factors remaining the same, The current buy back is equivalent to 11p per share.
Looking at it another way, they are buying shares for say 150p that have a tangible net asset value of 360p.
I might have to hold for another couple of years, unless they become a target for a takeover. In my view, there appears to be more upside than downside at this point.
- Forums
- ASX - By Stock
- Ann: 2023 Annual Report & Accs & Pillar 3 Disclosures
I was surprised the actual results were materially worse than...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VUK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.11 |
Change
0.010(0.24%) |
Mkt cap ! $2.190B |
Open | High | Low | Value | Volume |
$4.10 | $4.11 | $4.09 | $4.691M | 1.141M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 126411 | $4.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.11 | 80669 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 120322 | 4.100 |
2 | 32500 | 4.090 |
1 | 5000 | 4.070 |
1 | 7500 | 4.040 |
1 | 10 | 4.000 |
Price($) | Vol. | No. |
---|---|---|
4.110 | 78698 | 16 |
4.120 | 41772 | 16 |
4.130 | 10771 | 8 |
4.140 | 10508 | 2 |
4.150 | 47420 | 19 |
Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
$4.10 |
  |
Change
0.010 ( 0.24 %) |
|||
Open | High | Low | Volume | ||
$4.09 | $4.11 | $4.09 | 97890 | ||
Last updated 15.59pm 12/06/2024 ? |
Featured News
VUK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online